These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 11328982)

  • 1. PDL's mAb technology finds right timing.
    Fletcher L
    Nat Biotechnol; 2001 May; 19(5):395-6. PubMed ID: 11328982
    [No Abstract]   [Full Text] [Related]  

  • 2. Growing pains for biopharmaceuticals.
    Ashton G
    Nat Biotechnol; 2001 Apr; 19(4):307-11. PubMed ID: 11283578
    [No Abstract]   [Full Text] [Related]  

  • 3. A piece of history.
    Nat Biotechnol; 2003 Aug; 21(8):831. PubMed ID: 12894179
    [No Abstract]   [Full Text] [Related]  

  • 4. Monoclonal antibody successes in the clinic.
    Reichert JM; Rosensweig CJ; Faden LB; Dewitz MC
    Nat Biotechnol; 2005 Sep; 23(9):1073-8. PubMed ID: 16151394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The therapeutic antibodies market to 2008.
    Pavlou AK; Belsey MJ
    Eur J Pharm Biopharm; 2005 Apr; 59(3):389-96. PubMed ID: 15760719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoclonal antibodies market.
    Reichert J; Pavolu A
    Nat Rev Drug Discov; 2004 May; 3(5):383-4. PubMed ID: 15152631
    [No Abstract]   [Full Text] [Related]  

  • 7. Genentech and IDEC await approval of lymphoma Mab.
    Nat Biotechnol; 1997 Apr; 15(4):301. PubMed ID: 9094110
    [No Abstract]   [Full Text] [Related]  

  • 8. Monoclonal antibodies come of age.
    Ledford H
    Nature; 2008 Sep; 455(7212):437. PubMed ID: 18818613
    [No Abstract]   [Full Text] [Related]  

  • 9. Biotechnology. Go-ahead for Centocor.
    Gershon D
    Nature; 1991 Sep; 353(6340):101. PubMed ID: 1891035
    [No Abstract]   [Full Text] [Related]  

  • 10. State-of-the-art in downstream processing of monoclonal antibodies: process trends in design and validation.
    Marichal-Gallardo PA; Alvarez MM
    Biotechnol Prog; 2012 Jul; 28(4):899-916. PubMed ID: 22641473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Well-characterized biotechnology products: evolving to meet the needs of the 21st century.
    Zoon KC
    Dev Biol Stand; 1998; 96():3-8. PubMed ID: 9890510
    [No Abstract]   [Full Text] [Related]  

  • 12. Why these biotechs are as hot as net stocks. Wall Street's betting big on a genetic technology that burned it badly before. Monoclonal antibodies still don't cure cancer--but this time they may actually pay off.
    McLean B
    Fortune; 2000 Jan; 141(1):132-4, 135. PubMed ID: 10788044
    [No Abstract]   [Full Text] [Related]  

  • 13. Fast track to MS drug.
    Sheridan C
    Nat Biotechnol; 2004 Aug; 22(8):939-41. PubMed ID: 15286635
    [No Abstract]   [Full Text] [Related]  

  • 14. What's fueling the biotech engine-2007.
    Aggarwal S
    Nat Biotechnol; 2008 Nov; 26(11):1227-33. PubMed ID: 18997759
    [No Abstract]   [Full Text] [Related]  

  • 15. Mastering Biology.
    Hodgson J
    Biotechnology (N Y); 1991 Oct; 9(10):926, 928. PubMed ID: 1367803
    [No Abstract]   [Full Text] [Related]  

  • 16. Lymphoma treatment approved.
    AIDS Patient Care STDS; 1998 Mar; 12(3):231. PubMed ID: 11361944
    [No Abstract]   [Full Text] [Related]  

  • 17. Current regulatory and legal considerations for follow-on biologics.
    Kingham RF; Lietzan E
    Clin Pharmacol Ther; 2008 Nov; 84(5):633-5. PubMed ID: 18716615
    [No Abstract]   [Full Text] [Related]  

  • 18. New US committee considers xenotransplants.
    Fox JL
    Nat Biotechnol; 2001 Apr; 19(4):290-1. PubMed ID: 11283555
    [No Abstract]   [Full Text] [Related]  

  • 19. A testing approach based on tiny doses still awaits big results.
    Coombs A
    Nat Med; 2008 Aug; 14(8):796. PubMed ID: 18685584
    [No Abstract]   [Full Text] [Related]  

  • 20. [First monoclonal antibody accepted for cancer therapy].
    Itälä M
    Duodecim; 1998; 114(6):509, 511. PubMed ID: 11466914
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.